163 related articles for article (PubMed ID: 27029063)
41. Immune modulation and safety profile of adoptive immunotherapy using expanded autologous activated lymphocytes against advanced cancer.
Sun Z; Shi L; Zhang H; Shao Y; Wang Y; Lin Y; Li X; Bai C
Clin Immunol; 2011 Jan; 138(1):23-32. PubMed ID: 21041120
[TBL] [Abstract][Full Text] [Related]
42. Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy.
Aaronson DS; Yamasaki I; Gottschalk A; Speight J; Hsu IC; Pickett B; Roach M; Shinohara K
BJU Int; 2009 Sep; 104(5):600-4. PubMed ID: 19245439
[TBL] [Abstract][Full Text] [Related]
43. Prostate-specific antigen decline: a major prognostic factor for prostate cancer treated with radiation therapy.
Chauvet B; Félix-Faure C; Lupsascka N; Fijuth J; Brewer Y; Davin JL; Kirscher S; Reboul F
J Clin Oncol; 1994 Jul; 12(7):1402-7. PubMed ID: 7517443
[TBL] [Abstract][Full Text] [Related]
44. The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic carcinoma.
Zelefsky MJ; Leibel SA; Kutcher GJ; Kelson S; Ling CC; Fuks Z
Cancer J Sci Am; 1995; 1(2):142-50. PubMed ID: 9166467
[TBL] [Abstract][Full Text] [Related]
45. Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patients.
Satoh T; Teh BS; Timme TL; Mai WY; Gdor Y; Kusaka N; Fujita T; Pramudji CK; Vlachaki MT; Ayala G; Wheeler T; Amato R; Miles BJ; Kadmon D; Butler EB; Thompson TC
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):562-71. PubMed ID: 15145177
[TBL] [Abstract][Full Text] [Related]
46. Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV.
Michalski JM; Winter K; Purdy JA; Perez CA; Ryu JK; Parliament MB; Valicenti RK; Roach M; Sandler HM; Markoe AM; Cox JD
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):735-42. PubMed ID: 14967428
[TBL] [Abstract][Full Text] [Related]
47. Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer.
Mizoe JE; Tsujii H; Kamada T; Matsuoka Y; Tsuji H; Osaka Y; Hasegawa A; Yamamoto N; Ebihara S; Konno A;
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):358-64. PubMed ID: 15380567
[TBL] [Abstract][Full Text] [Related]
48. Lymphocyte subpopulations in peripheral blood in primary sclerosing cholangitis.
Panasiuk A; Prokopowicz D; Zak J; Panasiuk B; Wysocka J
Hepatogastroenterology; 2004; 51(59):1289-91. PubMed ID: 15362735
[TBL] [Abstract][Full Text] [Related]
49. Multicolor flow cytometry analysis of blood cell subsets in patients given total body irradiation before bone marrow transplantation.
Clave E; Socié G; Cosset JM; Chaillet MP; Tartour E; Girinsky T; Carosella E; Fridman H; Gluckman E; Mathiot C
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):881-6. PubMed ID: 7591898
[TBL] [Abstract][Full Text] [Related]
50. High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer.
Jo Y; Hiratsuka J; Fujii T; Takenaka A; Fujisawa M
Urology; 2004 Sep; 64(3):556-60. PubMed ID: 15351592
[TBL] [Abstract][Full Text] [Related]
51. Lymphocytic subpopulation changes after open and laparoscopic cholecystectomy: a prospective and comparative study on 38 patients.
Cristaldi M; Rovati M; Elli M; Gerlinzani S; Lesma A; Balzarotti L; Taschieri AM
Surg Laparosc Endosc; 1997 Jun; 7(3):255-61. PubMed ID: 9194291
[TBL] [Abstract][Full Text] [Related]
52. Three-dimensional conformal arc radiotherapy using a C-arm linear accelerator with a computed tomography on-rail system for prostate cancer: clinical outcomes.
Kumabe A; Fukuhara N; Utsunomiya T; Kawase T; Iwata K; Okada Y; Sutani S; Ohashi T; Oya M; Shigematsu N
Radiat Oncol; 2015 Oct; 10():208. PubMed ID: 26458948
[TBL] [Abstract][Full Text] [Related]
53. Carbon ion radiotherapy for treatment of prostate cancer and subsequent outcomes after biochemical failure.
Shimazaki J; Tsuji H; Ishikawa H; Okada T; Akakura K; Suzuki H; Harada M; Tsujii H
Anticancer Res; 2010 Dec; 30(12):5105-11. PubMed ID: 21187497
[TBL] [Abstract][Full Text] [Related]
54. Differences in toxicity and outcome associated with circadian variations between patients undergoing daytime and evening radiotherapy for prostate adenocarcinoma.
Hsu FM; Hou WH; Huang CY; Wang CC; Tsai CL; Tsai YC; Yu HJ; Pu YS; Cheng JC
Chronobiol Int; 2016; 33(2):210-9. PubMed ID: 26818960
[TBL] [Abstract][Full Text] [Related]
55. Sustained long-term immune responses after in situ gene therapy combined with radiotherapy and hormonal therapy in prostate cancer patients.
Fujita T; Teh BS; Timme TL; Mai WY; Satoh T; Kusaka N; Naruishi K; Fattah EA; Aguilar-Cordova E; Butler EB; Thompson TC
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):84-90. PubMed ID: 16472937
[TBL] [Abstract][Full Text] [Related]
56. Abnormalities of peripheral blood T lymphocytes and natural killer cells in alcoholic hepatitis persist after a 3-month withdrawal period.
Laso FJ; Madruga JI; López A; Ciudad J; Alvarez-Mon M; San Miguel J; Orfao A
Alcohol Clin Exp Res; 1997 Jun; 21(4):672-6. PubMed ID: 9194923
[TBL] [Abstract][Full Text] [Related]
57. Analysis of peripheral blood lymphocyte subsets in critical patients at ICU admission: A preliminary investigation of their role in the prediction of sepsis during ICU stay.
Frattari A; Polilli E; Primiterra V; Savini V; Ursini T; Di Iorio G; Parruti G
Int J Immunopathol Pharmacol; 2018; 32():2058738418792310. PubMed ID: 30114952
[TBL] [Abstract][Full Text] [Related]
58. [NK cell activity and counts of T-lymphocyte subsets in pulmonary tuberculosis].
Qin J
Zhonghua Jie He He Hu Xi Za Zhi; 1990 Aug; 13(4):209-11, 254. PubMed ID: 2151030
[TBL] [Abstract][Full Text] [Related]
59. Natural Killer Group 2A Expressed on Both Peripheral CD3
Yi RT; Niu YH; Liu HL; Zhang TY; Yang YC; Zhang Y; Yin DL; Chen TY; Zhao YR
J Interferon Cytokine Res; 2016 Dec; 36(12):689-697. PubMed ID: 27828717
[TBL] [Abstract][Full Text] [Related]
60. [Lymphocyte populations and subpopulations in peripheral blood of pregnant women with pre-eclampsia].
Dimitrakova-Dzhambazova E; Milchev N; Pavlov P; Dimitrakov D
Akush Ginekol (Sofiia); 2005; 44(1):40-4. PubMed ID: 15853011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
